The interaction of histamine with other bronchoconstrictor mediators

Canadian Journal of Physiology and Pharmacology
J F Burka


The lack of therapeutic efficacy of antihistaminic drugs in the treatment of asthma has led to the search and discovery of other bronchoconstrictor agents, particularly leukotrienes, thromboxanes, and platelet-activating factor. However, specific receptor antagonist for any of these substances have also not been particularly effective in inhibiting allergic bronchoconstriction. It is now generally accepted that histamine, arachidonic acid metabolites, platelet-activating factor, and possibly other substances are all involved to varying degrees in asthma and may indeed interact. This paper reviews the interaction of these mediators and how they contribute to airway hyperreactivity.


Mar 29, 1989·European Journal of Pharmacology·J MachováL Bilcíková
Feb 28, 1989·European Journal of Pharmacology·L DaffonchioB J Whittle

Related Concepts

Eicosatetraenoic Acids
Lobar Bronchus Structure
Platelet Activating Factor
Arachidonic Acid, Zinc Salt, (all-Z)-Isomer

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.